Cargando…

The miR-200 family is increased in dysplastic lesions in ulcerative colitis patients

BACKGROUND: Colorectal cancer (CRC) is a life-threatening complication of ulcerative colitis (UC), and patients are routinely screened for the development of precancerous lesions (dysplasia). However, rates of CRC development in patients with confirmed low-grade dysplasia vary widely between studies...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lewis, Amy, Felice, Carla, Kumagai, Tomoko, Lai, Cecilia, Singh, Kriti, Jeffery, Rosemary R., Feakins, Roger, Giannoulatou, Eleni, Armuzzi, Alessandro, Jawad, Noor, Lindsay, James O., Silver, Andrew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348010/ https://www.ncbi.nlm.nih.gov/pubmed/28288169 http://dx.doi.org/10.1371/journal.pone.0173664

Ejemplares similares

Familial adenomatous patients with desmoid tumours show increased expression of miR-34a in serum and high levels in tumours
por: Walton, Sarah-Jane, et al.
Publicado: (2016)

Epithelial down‐regulation of the miR‐200 family in fibrostenosing Crohn's disease is associated with features of epithelial to mesenchymal transition
por: Mehta, Shameer J., et al.
Publicado: (2018)

Benefit–risk assessment of golimumab in the treatment of refractory ulcerative colitis
por: Pugliese, Daniela, et al.
Publicado: (2016)

STMN1 accumulation is associated with dysplastic and neoplastic lesions in patients with ulcerative colitis
por: Osone, Katsuya, et al.
Publicado: (2019)

Intestinal Inflammation is Linked to Hypoacetylation of Histone 3 Lysine 27 and can be Reversed by Valproic Acid Treatment in Inflammatory Bowel Disease Patients
por: Felice, C., et al.
Publicado: (2020)

A case of periostomy intestinal metaplasia without adenomatous or dysplastic changes in an ulcerative colitis patient
por: Udechukwu, Nneka S., et al.
Publicado: (2020)

Mucosal healing in ulcerative colitis: surveillance or colectomy?
por: Andrisani, Gianluca, et al.
Publicado: (2013)

Knife-assisted resection of flat dysplastic lesions in colitis
por: Kandiah, Kesavan, et al.
Publicado: (2016)

Flow cytometric DNA ploidy pattern in dysplastic mucosa, and in primary and metastatic carcinomas in patients with longstanding ulcerative colitis.
por: Meling, G. I., et al.
Publicado: (1991)

Clostridium difficile Infection in Patients with Ulcerative Colitis Treated with Tofacitinib in the Ulcerative Colitis Program
por: Loftus, Edward V, et al.
Publicado: (2022)

Management of difficult-to-treat patients with ulcerative colitis: focus on adalimumab
por: Armuzzi, Alessandro, et al.
Publicado: (2013)

HLA Class I Expression Is Associated with DNA Damage and Immune Cell Infiltration into Dysplastic and Neoplastic Lesions in Ulcerative Colitis
por: Okami, Haruka, et al.
Publicado: (2023)

Combination of Endoscopic Resection and Heat Ablation Is a Promising Endoscopic Therapy for Adenoma-Like Dysplastic Lesion in Chronic Ulcerative Colitis
por: Matsumura, Kayoko, et al.
Publicado: (2009)

Array Comparative Genomic Hybridization in Ulcerative Colitis Neoplasia: Single Non-Dysplastic Biopsies Distinguish Progressors from Non-Progressors
por: Bronner, Mary P., et al.
Publicado: (2010)

The so-called dysplastic nevus is not dysplastic at all
por: Madan, Raman, et al.
Publicado: (2013)

Targeting IL12/23 in ulcerative colitis: update on the role of ustekinumab
por: Pugliese, Daniela, et al.
Publicado: (2022)

Colitis cystica profunda of the rectum with adenomatous dysplastic features: Radiologic-pathologic correlation
por: Rumi, Nicolò, et al.
Publicado: (2019)

Predictors of Sustained Response With Tofacitinib Therapy in Patients With Ulcerative Colitis
por: Sandborn, William J, et al.
Publicado: (2021)

Critical Appraisal of Filgotinib in the Treatment of Ulcerative Colitis: Current Evidence and Place in Therapy
por: Dal Buono, Arianna, et al.
Publicado: (2022)

Ulcerative Colitis: Shifting Sands
por: D’Haens, Geert R. A. M., et al.
Publicado: (2019)

A rare case of epiploic appendagitis in a patient affected by ulcerative colitis on vedolizumab therapy
por: Pugliese, Daniela, et al.
Publicado: (2022)

Unmet Medical Needs in the Management of Ulcerative Colitis: Results of an Italian Delphi Consensus
por: Daperno, Marco, et al.
Publicado: (2019)

The Borderline Dysplastic Hip: Arthroscopy or PAO?
por: Grammatopoulos, George, et al.
Publicado: (2018)

Treatment patterns among patients with moderate-to-severe ulcerative colitis in the United States and Europe
por: Armuzzi, Alessandro, et al.
Publicado: (2020)

ULCERATIVE COLITIS
Publicado: (1969)

Natalizumab in Crohn's disease: past and future areas of applicability
por: Armuzzi, Alessandro, et al.
Publicado: (2013)

Well-differentiated adenocarcinoma associated with ulcerative colitis
por: Yamamoto, Tomoko, et al.
Publicado: (2017)

Ulcerative Colitis Narrative Global Survey Findings: Communication Gaps and Agreements Between Patients and Physicians
por: Rubin, David T, et al.
Publicado: (2020)

Lipid Profiles in Patients With Ulcerative Colitis Receiving Tofacitinib—Implications for Cardiovascular Risk and Patient Management
por: Sands, Bruce E, et al.
Publicado: (2020)

Sustained Clinical Efficacy and Mucosal Healing of Thiopurine Maintenance Treatment in Ulcerative Colitis: A Real-Life Study
por: Pugliese, Daniela, et al.
Publicado: (2018)

Infliximab in ulcerative colitis
por: Levin, Avi, et al.
Publicado: (2008)

Ulcerative Colitis in Infancy
por: Rukunuzzaman, Md, et al.
Publicado: (2011)

Management of ulcerative colitis
por: Fell, John M, et al.
Publicado: (2016)

Chronic Ulcerative Colitis
por: Sen, S. C.
Publicado: (1939)

Chronic Ulcerative Colitis
por: Chopra, R. N., et al.
Publicado: (1939)

Mitochondria in Ulcerative Colitis
por: Stange, Eduard F.
Publicado: (2021)

Mildly dysplastic oral lesions with optically-detectable abnormalities share genetic similarities with severely dysplastic lesions
por: Brenes, David R., et al.
Publicado: (2022)

Efficacy and safety of tofacitinib dose de‐escalation and dose escalation for patients with ulcerative colitis: results from OCTAVE Open
por: Sands, Bruce E., et al.
Publicado: (2019)

Tofacitinib for induction of remission in ulcerative colitis: systematic review and meta-analysis
por: Paschos, Paschalis, et al.
Publicado: (2018)

Gastroduodenal Ulcerative Colitis in Association with Ulcerative Pancolitis
por: San Aye, Khin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_41jr0kve65o7nu0fo10rj1psc9